MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0350116

Медицинская библиотека · PloS one · 2026

Real-time detection of extravasation events of diagnostic and therapeutic radiopharmaceuticals in oncology.

Cucurachi Noemi, Fioroni Federica, Grassi Elisa, Panico Nicola, Verzellesi Laura, Botti Andrea, Fraternali Alessandro, Roncali Massimo, Durmo Rexhep, Filice Angelina, Iori Mauro

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Radiopharmaceutical extravasation-when injected activity remains in soft tissue rather than entering the bloodstream-can compromise quantification in positron emission tomography/computed tomography (PET/CT) and, in therapeutic settings, deliver high local radiation doses. These effects may lead to inaccurate Standardized Uptake Value (SUV) measurements, potential misdiagnosis, repeat examinations, and to avoid patient risk. We assessed a simple, real-time approach for detecting extravasation during administration to enable immediate management and quantitative correction.

RESULTS

Real-time monitoring with portable gamma detectors was applied to 885 diagnostic PET examinations (18F-FDG, 68Ga-DOTATOC/TATE, 68Ga-PSMA-11) and 15 administrations of 177Lu-DOTATATE therapy. In the diagnostic cohort, 53 extravasation events were identified and confirmed on PET images. Analysis of dose-rate-time curves yielded practical thresholds for extravasation detection: Δpinnor = 0.30 and ΔRt = 388 µSv/h. A statistically significant association was observed between SUV correction factors and specific curve parameters, enabling prospective adjustment of SUV before image interpretation. In the therapeutic cohort, one extravasation was observed, with an estimated absorbed self-dose of 11.6 Gy to the affected region. The monitoring enabled timely intervention that limited unnecessary exposure and workflow disruption. Feasibility analyses indicated that, for diagnostic procedures, a single detector can be sufficient for reliable extravasation identification and for deriving SUV correction factors.

CONCLUSIONS

A real-time, detector-based strategy can identify radiopharmaceutical extravasation during injection, support immediate mitigation, and preserve diagnostic accuracy by allowing early SUV correction. In therapeutic applications, it can reduce risk by prompting management of rare but consequential events. The operational simplicity, low cost, and effectiveness demonstrated across both diagnostic and therapeutic scenarios support integration of this approach into routine clinical practice, with the added practicality that a single detector appears adequate for diagnostic workflows.

Для цитирования: Cucurachi Noemi, Fioroni Federica, Grassi Elisa, Panico Nicola, Verzellesi Laura, Botti Andrea, Fraternali Alessandro, Roncali Massimo, Durmo Rexhep, Filice Angelina, Iori Mauro. Real-time detection of extravasation events of diagnostic and therapeutic radiopharmaceuticals in oncology.. PloS one. 2026. DOI: 10.1371/journal.pone.0350116.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.